Syneron Medical Ltd. (NASDAQ: ELOS) today announced that the FDA granted clearance to market its dental laser device, the LiteTouch. The LiteTouch dental laser was developed by Syneron subsidiary, Light Instruments, a company specializing in advanced dental laser devices.
The LiteTouch dental laser has been cleared by the FDA to be marketed in the US for a wide range of hard and soft tissue applications used in dentistry and oral surgery. Applications for which the LiteTouch has been cleared include, but are not limited to, caries treatment and removal and root canal procedures, as well as a wide range of oral and dental surgical procedures, such as the excision and incision of oral soft tissue, and dental implants.
The LiteTouch is a compact high power dental laser that is based on proprietary technology developed by the Light Instruments subsidiary of Syneron. The LiteTouch is ideally designed to fit into the space-limited dental office with a very compact user friendly design and very low maintenance cost. The LiteTouch has excellent performance parameters enabling fast and effective use by dentists and oral surgeons for a wide range of hard and soft tissue applications.
"We are very pleased with the clearance of the LiteTouch by the FDA," said David Schlachet, Syneron's CEO. "This device will complement our activity of selling aesthetic devices to dentists in the US under our recently launched dental spa program," Schlachet continued. "Now with FDA clearance, the marketing of the LiteTouch will open up even further cross selling opportunities for Syneron's core medical aesthetic devices to the very large market of general dental practices in the US."